Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Caroen

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Respiratory Medicine Case Reports|June 23, 2016
Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLCCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 12, 2021
RRx-001, a downregulator of the CD47- SIRPα checkpoint pathway, does not cause anemia or thrombocytopeniaBryan Oronsky, Pedro Cabrales, Scott Caroen, et al.
Future Oncology (London, England)|July 28, 2023
TGF-β: the apex predator of immune checkpointsBryan Oronsky, Pedro Cabrales, Babak Alizadeh, et al.
Journal of Cancer|August 1, 2022
A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)Bryan Oronsky, Nacer Abrouk, Scott Caroen, et al.
Cancer Metastasis Reviews|August 23, 2024
Lost at SCLC: a review of potential platinum sensitizersBryan Oronsky, Nacer Abrouk, Li Mao, et al.
Case Reports in Oncology|April 3, 2023
Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma PatientSantosh Kesari, Jeannie Williams, Erica Burbano, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Case Reports in Oncology|July 13, 2016
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum DoubletsCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Case Reports in Oncology|May 18, 2017
Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case ReportNeil Oronsky, Bennett Thilagar, Carolyn M Ray, et al.
Expert Opinion on Investigational Drugs|December 11, 2020
Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinomaMin-Jung Lee, Yusuke Tomita, Akira Yuno, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Respiratory Medicine Case Reports|June 23, 2016
Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLCCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 12, 2021
RRx-001, a downregulator of the CD47- SIRPα checkpoint pathway, does not cause anemia or thrombocytopeniaBryan Oronsky, Pedro Cabrales, Scott Caroen, et al.
Future Oncology (London, England)|July 28, 2023
TGF-β: the apex predator of immune checkpointsBryan Oronsky, Pedro Cabrales, Babak Alizadeh, et al.
Journal of Cancer|August 1, 2022
A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)Bryan Oronsky, Nacer Abrouk, Scott Caroen, et al.
Cancer Metastasis Reviews|August 23, 2024
Lost at SCLC: a review of potential platinum sensitizersBryan Oronsky, Nacer Abrouk, Li Mao, et al.
Case Reports in Oncology|April 3, 2023
Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma PatientSantosh Kesari, Jeannie Williams, Erica Burbano, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Case Reports in Oncology|July 13, 2016
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum DoubletsCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Case Reports in Oncology|May 18, 2017
Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case ReportNeil Oronsky, Bennett Thilagar, Carolyn M Ray, et al.
Expert Opinion on Investigational Drugs|December 11, 2020
Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinomaMin-Jung Lee, Yusuke Tomita, Akira Yuno, et al.
Pageof 6